XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona to Present at the 41st Annual J.P. Morgan Healthcare Conference

Dentsply Sirona to Present at the 41st Annual J.P. Morgan Healthcare Conference

CHARLOTTE, N.C., Dec. 20, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the company will participate in the 41st Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 11, 2023, at 10:30 am PT (1:30 pm ET).

Investors and other interested parties will be able to access a live audio webcast of the presentation and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at .

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

Andrea Daley

VP, Investor Relations





EN
20/12/2022

Underlying

XRAYDENTSPLY SIRONA Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Reports Second Quarter 2025 Results

Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impactGAAP gross margin of 52.4%, GAAP net loss per share of ($0.22)Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52Executed $550 million debt offeringReaffirmed FY25 outlookLeadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Si...

August 7, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the “Board”), has been appointed President and Chief Executive Officer, effective A...

July 21, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Dentsply Sirona to Host Second Quarter Conference Call on August 7th CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website at prior to t...

July 10, 2025 1 EN
 PRESS RELEASE
Free
XRAY DENTSPLY SIRONA...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions. The notes will bear interest at a fixed rate of 8.375% per year until September 12, 2030 (the “First Reset Date”). On and after the Fi...

June 5, 2025 1 EN
EUR 154.91
XRAY DENTSPLY SIRONA...

Moody's Ratings assigns Baa3 rating to Dentsply Sirona's proposed hybr...

Moody's Ratings (Moody's) assigned a Baa3 rating to Dentsply Sirona Inc.'s ("Dentsply Sirona") proposed offering of junior subordinated notes ("hybrid"). At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook ...

XRAY DENTSPLY SIRONA INC.
06/04/25 June 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch